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Abstract
Background: Intelligent and multitiered quantitative analysis of biological systems rapidly evolves to a key
technique in studying biomolecular cancer aspects. Newly emerging advances in both measurement as well as
bio-inspired computational techniques have facilitated the development of lipidomics technologies and offer an
excellent opportunity to understand regulation at the molecular level in many diseases.
Results: We present computational approaches to study the response of glioblastoma U87 cells to gene- and
chemo-therapy. To identify distinct biomarkers and differences in therapeutic outcomes, we develop a novel
technique based on graph-clustering. This technique facilitates the exploration and visualization of co-regulations
in glioblastoma lipid profiling data. We investigate the changes in the correlation networks for different therapies
and study the success of novel gene therapies targeting aggressive glioblastoma.
Conclusions: The novel computational paradigm provides unique “fingerprints” by revealing the intricate
interactions at the lipidome level in glioblastoma U87 cells with induced apoptosis (programmed cell death) and
thus opens a new window to biomedical frontiers.
Background
Glioblastoma are highly invasive brain tumors. The
prognosis for patients with glioblastoma depends on
many factors, including age, performance status, and
histology grade of the glial neoplasm. The medial survi-
val is approximately 14 months with maximal therapy.
Glioblastoma are difficult to treat due to the resistance
to conventional therapies as well as the ability to diffuse
throughout the brain. Therefore, analytical description
of tumor growth and response to therapeutic modalities,
such as radiation and chemotherapy, has been a central
research topic. Modeling of the tumor responding to
chemotherapy is mostly of pharmacokinetic nature [1].
Other mathematical models are based on a conservation
equation describing a modality of how to measure the
growth of an infiltrating glioma [2]: the rate of change
of tumor cell population equals the diffusion (motility)
of tumor cells plus the net proliferation of those. Cell
death is introduced as a loss term in [3]. A model
combining patient’s imaging, histopathologic and phar-
macodynamic/genetic data when treated with temozolo-
mide is presented in [4].
Interesting aspects of glial cell biology have recently
been uncovered in laboratories evaluating the tumor sup-
pressor protein wild type 53 (wt p53) [5,6]. It is well estab-
lished that transfecting glioma cells with wild-type tumor
protein p53 will trigger brisk apoptosis if the cell line har-
bors mutant p53, while the same transfection to cell lines
which harbor the wt p53 will result in a reduction or elim-
ination of invasion and motility [7]. A glioma cell line that
harbors the wild-type form of the tumor suppressor pro-
tein p53 can be sensitized to undergo apoptosis by the
addition of wt p53 along with chemotherapy (such as
SN38) [5,6]. Recently, new insights into the pathobiology
of glioblastoma cells have been obtained at the M.D.
Anderson Cancer Center in Houston, Texas: transfer of
the p53 gene by use of an adenovirus vector (Ad-p53) may
be clinically applicable in human gliomas. Furthermore, it
has been demonstrated that combined adenovirus trans-
fection of wild-type p53 (wt p53) into glioma cells fol-
lowed with chemotherapy treatment SN-38 may act to
convert gliomas to an “apoptosis-sensitive” phenotype [8].
Moreover, wt p53 containing tumor cells, such as U87
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matrigel motility assays after wt p53 gene therapy. A pro-
teomic approach identified proteins that were involved in
a phenotypic change in the high-grade glioma cell line
U87 MG under the influence of transfection with wild-
type p53 and additional cytotoxic chemotherapy with
SN-38 [6]. This study showed that the expression of the
protein galectin-1 is associated with malignancy and poor
prognosis. The results suggest that galectin-1 is a relevant
therapeutic target to downregulate in a clinical pharmaco-
logical setting to improve overall survival of high-grade
glioma patients. Our current understanding of proteins
such as galectin-1, interactions and pathways is detailed,
yet it is still incomplete. Galectin 1 binds free beta-galac-
tose residues on both glycoproteins and gangliosides
(GM1 and asialo-GM1 gangliosides are known to be galec-
tin-1 ligands) [9]. Gangliosides were first discovered by the
German scientist Ernst Klenk in 1942. They are cell-type
specific antigens that provide cell membrane structure,
and play key roles in control growth, cell differentiation
and cell/cell interactions. Gangliosides are implemented in
different cancer types (such as glioblastoma) since some
typical gangliosides are present in tumors, but are absent
in normal healthy tissue [10].
Although connections between cancer and glycobiology
have been described, the detailed chemical analysis of
polar lipids has been problematic due to structural com-
plexity as well as limitation of analytical techniques.
Recently, He et al. [11] pioneered new analytical metho-
dology with nano-liquid chromatography (nano-LC)
separation followed by high mass accuracy and high
mass-resolving power Fourier transform ion cyclotron
resonance (FT-ICR) mass spectrometry (MS) analysis at
14.5T [12]. MS is useful in dealing with complex mix-
tures since the high mass resolution (narrow peak width)
allows the signals of two ions of similar mass-to-charge
ratio (m/z) to be detected as distinct ions. This new
methodology has opened a new field of polar lipid profil-
ing. A typical biological analysis from 2 million cells
results in the identification of 600-800 different polar
lipids of various polar heads and variable size and modi-
fied (degree of saturation andh y d r o x y l a t i o n )n o n p o l a r
tails. Relative quantification of each polar lipid between
treated and untreated cells results in highly complex,
information rich data sets. The ultimate goal of this
research is to link the changes in the polar lipids to the
enzymes that control their synthesis/modifications/degra-
dation (gene arrays and functional proteomics), which
will provide a systems biology approach to the study of
glioblastoma. The data generated will be used to drive
logical, hypothesis driven experiments in the search for
new therapeutic targets in glioblastoma research.
Since the lipid profiling methodology generates com-
parative semi-quantitative data on hundreds of different
polar lipids with each experiment, the data analysis has
become a daunting task. Novel approaches [13-15] are
now needed to compile the existing biological lipid pro-
filing experimental data and to maximize the informa-
tion extraction from these databases. Once correlations
in the lipid database have been identified, the reduced
data will be correlated to the gene array data and pro-
teomic data sets. This manuscript describes a novel
algorithm for identification of correlations in the com-
plex lipid data sets derived from gene treated and empty
vector treated U87 glioblastoma cell lines. We research,
implement and test graph clustering techniques as an
equivalent to standard correlation networks. This novel
approach combines analysis and visualization with the
correlation structure of the lipid profiling data. This
novel technique enables a better understanding and a
mathematical analysis of the observed experimental
results.
Results and Discussion
In this paper we develop a novel paradigm to replace
correlation networks standardly employed for displaying
the topological properties of networks [16,17]. Tradi-
tional correlation networks are based on building a
graph and determining the correlation scores between
the nodes of the graph and then compare those values
with a given threshold. For those exceeding the thresh-
old an undirected edge is linked between the nodes. As
a novel concept in this paper, we research, implement
and test graph clustering techniques as an equivalent to
standard correlation networks for the analysis of thera-
peutic outcomes for U87 MG glioblastoma cells.
Global multivariate approaches such as the proposed
novel graph clustering correlation network are needed
in order to understand the potential disregulation of
normal cellular responses in disease and their response
to various therapeutic interventions. Moreover, because
nano-LC/MS can find and assign hundred of lipids from
glioma cells, it is possible to identify causal influence
relationships involving multiple lipids. Building upon
lipid measurements such as those illustrated in Figure 1
for the group of gangliosides for two treatments (here,
treatments one and two listed in Table 1), Figure 2
shows the schematic of the graph clustering network
based on multidimensional lipidomic data. The correla-
tion structure is explored by varying the threshold
between different lipids and the important changes
between treatments by clusters of nodes of different
sizes and fan-out degrees.
A Graph Model based on Correlation Networks
The notion of networks has recently started to perme-
ate diverse fields of science as well as numerous con-
cepts in our everyday lives. This development roots
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which spawned many concepts and methods that today
experience a renaissance empowered by the ubiquity
and availability of social networks, especially in the
internet (another, technical network). The driving
force behind the rise of this concept is the fact that a
network is a very apt and well-perceivable representa-
tion of the interrelation of things. For this reason, we
advocate the use of network analysis [18] in the field
of lipidomics. Generally speaking, any set of interre-
lated entities constitutes a network, and can thus be
modeled as a graph, which is the mathematical forma-
lization of the term network. The evidence that lipids
are related in their reaction to treatments leads to the
fact that exploration and visualization of co-regulations
in glioblastoma data can be done based on correlation
network analysis. Such networks describe all depen-
dencies between the domain variables. More precisely
we define the simple (neither self-loops nor parallel
edges are allowed), undirected (edges represent a
mutual relationship) and weighted graph G =( V, E, ω)
as follows. The set V of nodes is the set of all mea-
sured lipids while the set E of edges (i.e nodes pairs)
describes the dependencies between these lipids by a
weight function ω : E ® [0, 1] which expresses the
strength of the dependencies. In our case ω is based
on a matrix of correlation coefficients which is com-
puted based on the pair-wise correlation between the
concentrations of lipids in a given sample. Thus, for an
edge e ={ u, v}, the weight ω (e)i sam e a s u r eo fc o r r e -
lation, i.e., similarity between lipids u and v,w i t ha
value of 1 indicating identical measurements x and y,
and values close to 0 indicating very different measure-
ments. We base our correlation matrix on measured
values x normalized with the standard normalization
function f(x)=l o g ( x+1). However, since this proved to
be too non-discriminative for network analysis techni-
ques, we actually used f′(x)=( f(x))
3. The correlation of
two measurements x and y is then computed as cor(x,
y)=m i n { f′(x), f′(y)}/max{f′(x), f′(y)}, with the special
case of cor(x, y)=1i fx = y =0 .
Figure 1 Gangliosides profiles for the two treatments U87+DI312/24hr+SN38/24hr and U87+p53/24hr+SN38/24hr. Ganglioside profiles
for the polar lipid fraction of extracts of U87 cells following two different treatments. The effect of treatment with wild-type wt p53, which
lowers the abundance of longer chain ceramides, is most pronounced for the GM1b and GD1 gangliosides. Figure extracted from [11] and
awaiting copyright permission.
Table 1 Treatment conditions of U87 Glioblastoma Cell
Cultures.
Treatment conditions of U87 Glioblastoma Cell Cultures.
Condition Abbreviation
Treatment 1 U87 + DI312/24h + SN38/24h
Treatment 2 U87 + p53/24h + SN38/24h
Treatment 3 U87 + SN38/24h + DI312/24h
Treatment 4 U87 + SN38/24h + p53/24h
Treatment 5 U87 + DI312
Treatment 6 U87 + p53/24h
Treatment 7 U87 + SN38/24h
Control U87 cell only
Görke et al. BMC Systems Biology 2010, 4:126
http://www.biomedcentral.com/1752-0509/4/126
Page 3 of 15Since in this work we divide our studies up into differ-
ent groups of lipids, i.e., gangliosides, phosphatidylinosi-
tol and phosphatidylglycerol, we construct three
different base-networks for our exploratory clusterings,
one for each group. Actual lipid correlation graphs are
then obtained by choosing a treatment and a threshold
value for the correlation coefficient values, i.e., edges
with insignificant weights are pruned. Two nodes u and
v that are connected by an edge are called adjacent, and
an edge e and an end node v of e are called incident,
abbreviated by u ~ v and e ~ v, respectively. Figure 3 is
the network of phosphatidylglycerols. For the sake of
readability we do not state full names of lipids in our
graphs, but instead denote the index of the lipid in the
corresponding chart (as, e.g., in Figure 3 for phosphati-
dylglycerols). The layout (i.e., the positions of nodes in a
drawing) is determined with so called force-directed
graph-drawing techniques. Roughly speaking, strong ties
draw nodes together and weak ties let them drift apart.
Heavier edges are darker than lighter edges and larger
nodes share many heavy edges with other nodes. We
can now identify groups of lipids that exhibit a similar
behavior.
Graph Clustering on Correlation Networks
We propose and tested a novel concept for analyzing
correlation networks based on graph clustering. In Fig-
ure 3 we can easily perceive three rather densely knit
groups of lipids, which share mostly weak links (if at all)
to the other groups. Such a dense subset indicates that
these lipids correlate strongly with each other wrt. to
their reaction to the applied treatment, i.e., it is a cluster
of similarly behaving lipids. While in a single small
example this might be done by hand, this task is usually
realized with graph clustering [18,19] algorithms, which
automatically identify a clustering. Clustering methods
discover natural concentration and large-scale inhomo-
geneities in relational data. A clustering  G () of a
graph G =( V, E) is a partition  = {} CC k 1,..., of the
set V of nodes into clusters Ci (remember that a parti-




=1  and Bi ∩ Bj = ∅, ∀ i ≠ j Î {1, ..., k}).
Clusterings always follow the paradigm of intra-cluster
density vs. inter-cluster sparsity. In other words, the
edge-connectivity inside clusters is to be strong, while
between clusters there should only be few, or light-
weighted edges. In our context this means that the pair-
wise correlations of nodes inside one cluster are all
rather high, and those of nodes in different clusters are
comparably low. It is important to note that the number
of clusters to be found is not preset by a parameter,
instead it is determined by the algorithm and the
instance. Since edge weights represent the strength of
ties, our graph clustering algorithm takes these edge
weights into account, which yields a higher precision
than pruning light edges and then employing an un
weighted algorithm. For the sake of readability, we still
use the pruning only for our drawings.
Figure 2 Lipidomic platform data processing. Graph clustering modeling with U87 MG glioblastoma cell data. The schematic shows a
resulting correlation based on nano-LC/MS data. Seven different treatments are applied to a cell line. Graph clustering analysis is performed on
this data and a correlation diagram reflecting dependencies in the underlying network is obtained. Abbreviations. PG means
phosphatidylglycerol, PS means phosphatidylserine, PI means phosphatidylinositol, PE means phosphatidylethanolamine, GA means gangliosides
and SU means sulfatide.
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intra-cluster density vs. inter-cluster sparsity requires
amathematical formalization. A very simple such for-
mula is coverage, which measures the fraction of thetotal
edge weight which is covered by (i.e., inside) clusters
(see Formula 1). While, for a given clustering, coverage
is a simple, yet decent measure for clustering goodness,
trying to maximize it is unreasonable, as an optimal cov-
erage value of 1 is attained by setting  = {} C1 with C
=V , i.e., using only one cluster. Among the established
graph clustering algorithms that have successfully been
applied to networks with similar structure in the past
are algorithms that maximize the quality index modular-
ity [20], which builds upon coverage. Roughly speaking,
Figure 3 Example of a correlation network for phosphatidylglycerols for U87+SN38/24hr.Ac o r r e l a t i o nn e t w o r ko ft h eg r o u po f
phosphatidylglycerols wrt. treatment 7 (see Tab. 1), based on a threshold of 0.3.
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scale from -1 to 1) by comparing the coverage of a clus-
tering to the expectation of this value if edges were
rewired randomly. Equations (1) and (2) give the formu-
las for coverage and modularity, respectively:
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For the purpose of this article it is unnecessary to
delve into the details of modularity, we refer the reader
to [21-23] and further references therein. The rationale
behind modularity is as follows. Given some clustering,
a very low modularity tells us that even a purely random
network would t the clustering better than the given
graph, while a high modularity score means that the
identified clustering captures very well how edges differ
from randomness and constitute dense groups. The
modularity of given clustering can be computed in lin-
ear time (linear in |V| + |E|), however, identifying a
clustering with a high modularity is harder. In fact it is
NP-hard to actually optimize modularity [21], thus heur-
istics are used, of which a localized agglomerative
approach [24] is the current state of the art, which we
also use in this work. (The term “NP-hard” from theore-
tical computer science indicates that it is highly unlikely
that an algorithm with a practicable–subexponential in
the size of the input–running time for large instances of
this problem exists, roughly speaking, a heuristic is a
strategy which does a good job, but no qualitative guar-
antee about its behavior can be given a priori.) We
repeated our experiments with other graph clustering
algorithms such as ORCA[25], which is strong on very
large graphs, minimum-cut tree clustering [26], which is
able to guarantee certain bottleneck properties of clus-
ters, and iterative conductance clustering [27], which fea-
tures a parameterized clustering coarseness. However,
the constructed graphs are not large and we do not
impose any specific requirements on the clustering,
instead we intend to learn from the clustering and get
an impression of the network. For these reasons, a self-
contained modularity-based algorithm worked best for
our purpose.
The algorithm we use [21] initializes each node as a
singleton cluster, i.e., containing only this one node.
Then, iteratively, each node explores its local graph
neighborhood, leaves its current cluster and joins the
best neighbor cluster, if such a swap yields an increase
in modularity. This process usually merges many clus-
ters. The iteration is repeated until annealed, which
means that modularity can no further be improved by
m o v i n ga n ys i n g l en o d et oad i fferent cluster. Resulting
clusters are then abstracted to super-nodes, which
means that a new graph is constructed, where each
node represents a cluster in the original graph, and
edges between original nodes are summarized into
super-edges in the abstracted graph. In this resulting
graph, the above process is repeated. Eventually, at
some abstraction stage, modularity will attain its peak
and no node will join any other’s cluster, then the
abstraction hierarchy is unfurled and the final super-
nodes induce the clustering of the original graph. Figure
4 is an example clustering of treatment 6 of the
phosphatidylglycerols.
Difference Graphs and Visualization of Lipidomic Changes
For each treatment (see Table 1) and for each group of
lipids we now design a correlation network as described
in the previous section, and identify a graph clustering.
Each clustering reveals subsets (clusters) of lipids which
exhibit a very similar reaction to this treatment. Thus,
roughly speaking, lipids within the same cluster can be
grouped in terms of their behavior and, on the other
hand, are more or less well separated from lipids in
other clusters in this respect.
Generally speaking, comparing a treatment to others,
e.g., a control, is of particular interest. Thus, in order to
compare a first treatment a to a second treatment b of
the same group of lipids, we combine two graphs and
their clusterings in one new graph layout, the difference
graph, as follows. a’s clustering is represented by boxes,
such that each box constitutes a cluster, and b’sc l u s t e r -
ing by node colors, i.e., subsets of nodes with the same
color constitute clusters. Comparing these clusterings
yields many insights, which are immediately observable
in a readable layout. It shows us how differently the two
treatments “correlated the lipids”. A cluster of lipids
that react almost identically wrt. a might be split into
different clusters in b’s clustering, which strongly indi-
cates that the split apart nodes (i.e., lipids) share a prop-
erty that makes them sensitive to treatment b.T h i s
selectively leads us back to specific places in the raw
data, where we now know what to look for. In particu-
lar, this might even point to some biochemical feature
of these lipids, the relevance of which has not yet been
known. We will demonstrate this in the illustration
below.
A sas i d en o t e ,t h e r ei ss o m el i t e r a t u r eo nq u a n t i t a -
tively comparing clusterings of graphs or partitions of
data points. A good overview of this field, with an
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is given in [28]. A multitudeo fd i f f e r e n c em e a s u r e s
for clusterings exists, with perhaps the most prominent
one being the Rand measure [29], which is the
fraction of node pairs, which are co-classified in
the same way by both clusterings, i.e., twice together
or twice separated. Technically speaking, for two
clusterings 1 and 2 of graph G =( V, E)s e t
nu v C C
V
tog. |{{ , } ( )| , =∈ ∃ ∈ ∈ 21 1 2 2  such that u, v
Î C1 and u, v Î C2}|, and set nsep. analogously for u, v
separated, then Rand n n
V ( , ) ( )/|( )}|. ..  12 2 =+ tog sep
Using such a measure of comparison in our application
would give a vague impression about how much treat-
ments differ in terms of correlation of lipid reaction
without looking at the graphs or knowing how the dif-
ference manifests. Using any such measure requires
care and experience as they are prone to biases intro-
duced by the size of a network and the coarseness of
the clusterings. Since, additionally, we clearly focus on
qualitative differences, which, for small graphs such as
those in our application, our figures give a good
impression about, we do not use difference measures.
Since the edge structure of the two compared graphs
a r ea l r e a d yt r a n s f e r r e di n t oc l u s t e r i n g s ,w eh a v et h e
edges of the new difference graph represent more press-
ing information. the weight of edge {u, v} in a difference
graph is its weight wrt. am i n u sits weight wrt. b.T h e
crucial observation is as follows. This weight shows how
treatments a and b differ in terms of the behavior of u
and v;i ft h i sw e i g h ti sc l o s et oz e r o ,t h e ns w i t c h i n g
from a to b does not discriminate u and v,i fi ti sp o s i -
tive (negative), then u and v correlate stronger (weaker)
wrt. treatment a than wrt. b. We color edges on a linear
HSV-scale (from blue = cold = small difference to red =
hot = large difference) by the absolute value of this new
edge weight. Thus, edge colors indicate whether switch-
ing between treatment a and b discriminates nodes.
However, in order not to overburden the drawing, col-
ors encode only the absolute difference between the a
and b’s correlations; this hints at where to look for
interesting behavior, and detailed quantities can then be
read o edge annotations or the raw data. Furthermore,
we size nodes proportionally to sum of their incident
absolute edge weights. Thus, in a difference-graph for a
and b, a node is large if it differs strongly in its correla-
tions to other nodes wrt. the two treatments, there
should thus be several heavy (i.e., warm-colored) inci-
dent edges on such a node. Small nodes roughly pre-
serve their correlation behavior in both treatments.
Illustration of the Approach
Our approach is illustrated by computing the graph-
correlation networks resulting from gene therapy for
gangliosides, phosphatidylinositol and phosphatidylgly-
cerol. In the following we illustrate what can be con-
cluded from the networks constructed from these
different groups of lipids, as shown in their respective
figures. Please note that we do not predetermine the
numbers of clusters, thus different treatments can very
well yield different numbers of clusters, this simply
reflects that the numbers and sizes of lipids with simi-
lar behavior depend on which treatment is used. We
exemplarily show the resulting correlation networks
Figure 4 Example of graph-clustering correlation network for phosphatidylglycerols for U87+p53/24hr.T h ec l u s t e r e d
phosphatidylglycerols wrt. treatment 6 (threshold of 0.5). Cluster 1 can also be observed in Fig. 3, cluster 3 includes most other lipids as they
behave more similar than for treatment 7, only nodes 2 [(32:0)+O] and 4 [(32:1)+O] are further distant, their weak tie (0.25 < threshold) is pruned
visually.
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strong difference of the first two treatments from
T a b l e1a n dF i g u r e5 .I nF i g u r e5 ,t h er e s u l to ft h e
control treatment one is summarized by the box-clus-
tering, and the treatment two (p53), is depicted by
node colors. A first observation is that the control
yields only two clusters of lipids (boxes), and adding
p53 yields three (colors), thus, treatment two discrimi-
nates the reaction of lipids more finely. The red cluster
is striking as it contains many large nodes, i.e., lipids,
which differ strongly in their correlations wrt. the two
treatments. The fan-out degree of every single lipid
component in these graphs shows us the modulation
degree with a given treatment. The hot (reddish) edges
incident to the largest nodes show where these differ-
ences manifest most strongly, i.e., which other nodes
are discriminated by such a node (and its cluster) by
moving from treatment one to treatment two. Looking
up the respective lipids in Figure 1, the graphical clus-
tering thus confirms the experimental results by show-
ing that the long chain gangliosides go down after p53
treatment. In a similar manner we can use our graphs
of other groups of lipids and treatments for pointers to
behavioral phenomena. For the ratio of the third and
fourth treatment combinations and the fifth and sixth,
respectively, from Table 1, we do not observe any rele-
vant changes as shown in Figure 6 and 7.
For the phosphatidylinositol (PI), we see in Figure 8
the experimental outcome for the first two treatments
showing an abundance increase of hydroxilated PIs. We
can also see that the hydroxylated PI go up after p53
treatment as depicted from the difference network
between the first two treatments in Figure 9. The high-
est increase from zero to one hundred for (38:6)+O as
shown in the experimental results is represented in the
network as a distinct separate cluster. There are no sig-
nificant changes between the treatments U87+SN38/
24hr+DI312/24hr versus U87+SN38/24hr+p53/24hr and
U87+DI312/24hr versus U87+p53/24hr.
The biochemical observations are again confirmed by
our analysis for the phosphatidylglycerol (PG) profiles.
The results for the first two treatments only are visua-
lized in Figure 10 showing an abundance increase of
hydroxylated PGs. The correlation network confirming
these results is shown in Figure 11. Cluster 2 includes
only the two PGs (32:0)+O and (32:1)+O showing an
increase in signal magnitude from 0 for the first treat-
ment to 100 for the second one. There are again as
Figure 5 Graph-clustering correlation network for gangliosides showing the difference between U87+DI312/24hr+SN38/24hr and U87
+p53/24hr+SN38/24hr. Correlation network resulting from graph-clustering data analysis for a correlation threshold > 0.6 for gangliosides
showing the difference between the first two treatments (i.e., edge weights = cor(T1) - cor(T2)). The clustering for T1 (boxes) automatically
divides into small-value (cluster 2) and high-value lipids (cluster 1), see Table 1. T2’s clustering (colors) distinguishes further: high values (green
nodes), intermed. values (blue nodes), and very small values (red nodes). Thus, red nodes in the right hand box show the strongest decrease
when switching to T2. In particular, v31 = GD1 (d18:1/24:0) and v32 = GD1 (d18:1/24:1) show the highest change. in T1 they react similarly as
several green nodes (e.g., v5 = GM3 (d18:1/16:1)), which they do not do for T2, as evident from the many heavy-difference edges incident to
nodes v32 and v31. Also significant are v30 = GD1 (d18:1/23:1), v22 = GM1b (d18:1/23:0) and v21 = GM1b (d18:1/22:0), which, by their very small
values in T2 set themselves apart from many others (heavy edges).
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ments U87+SN38/24hr+DI312/24hr versus U87+SN38/
24hr+p53/24hr and U87+DI312/24hr versus U87+p53/
24hr.
We want to emphasize - based on the achieved results
- that graph clustering networks compared to traditional
correlation networks represent a unique “fingerprint” in
lipidomics by revealing analytic properties while display-
ing the graph structure. This term from the field of ana-
lytic visualizations signifies a superficial drawing on the
one hand, as it masks or even ignores some aspects of
the raw data, however, on the other hand, it implies that
prominent and potentially unknown features of the data
become visible in an easily recognizable way. The above
investigations show how observations made with the
help of our clusterings coincide with and corroborate
findings and interpretations based on expert knowledge.
Graph clustering and visualizations certainly cannot
replace traditional analysis, but they can be a powerful
supporting tool.
Figure 6 Graph-clustering correlation network for gangliosides showing the difference between U87+SN38/24hr+DI312/24hr and U87
+SN38/24hr+p53/24hr. Correlation network resulting from graph-clustering data analysis for a correlation threshold > 0.6 for gangliosides
showing no significant changes between the treatments U87+SN38/24hr+DI312/24hr (T3, boxes) versus U87+SN38/24hr+p53/24hr (T4, colors).
Here, v16 = GM2a (d18:1/24:0) leaves the box of blue nodes in T4, as T4 discriminates it from the blue nodes’ values. Despite of low differences in
correlation between T3 and T4, in T3 (boxes) there are three different clusters induced by groups of similarly behaving lipids, and only two for T4.]
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Page 9 of 15Conclusions
In this paper, we analyzed and interpreted lipidomic
data sets acquired by high-throughput measurements
such as nano liquid chromatography (nano-LC) separa-
tion followed by detection with high mass accuracy and
high mass-resolving power 14.5 FT-ICR MS. The sam-
ples were taken from U87 cell line treated under seven
different treatments. We hypothesize that the observed
correlations between the gangliosides concentrations are
a result of the underlying lipidomic reaction network.
Thus, lipidomic networks in glioblastoma represent
highly dynamical processes continuously changing under
the influence of fluctuations. These induce a specific
pattern of correlations and arem e a s u r e di nt h ee x p e r i -
ment as a result of network propagation.
As seen in plant metabolism [16], the determined
pair-wise correlations represent a snapshot or “finger
print” of the biochemical state of the glioblastoma cell
at a given point in time. We introduced a novel concept
in correlation network, the so-called graph clustering
approach, which results in finding not only the correla-
tions but also the clusters in these networks providing
thus based on the concept of modularity a better visuali-
zation and analysis in lipidomic data exploration.
The simulations based on the novel theoretical
concept have confirmed the experimental findings: a
Figure 7 Graph-clustering correlation network for gangliosides showing the difference between U87+DI312/24hr and U87+p53/24hr.
Correlation network resulting from graph-clustering data analysis for a correlation threshold > 0.6 for gangliosides showing no significant
changes between the treatments U87+DI312/24hr (T5, boxes) versus U87+p53/24hr (T6, colors). Most notably, the size of v27 = GD1 (d18:1/16:0)
and v4 = GM3 (d18:1/16:0)+O show their deviation from the behavior of the other nodes in the upper cluster, for T6, the two move to the red
cluster. Most others do not di er heavily in their correlations.
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Page 10 of 15down-regulation for gangliosides and an up-regulation
for sulfatides and phosphatidylinositol. Furthermore, we
could quantize the regulations across the whole lipidom
showing additionally that hydroxylated phosphatidylgly-
cerol is also up-regulated. Among the seven possible
treatments, we showed that most visible changes leading
to apoptosis can be found in combination with adeno-
virus therapy.
In summary, this paper revealed in an unique way the
“fingerprints” in lipidomics showing us how gene ther-
apy (adeno virus) with wild type p53 followed by che-
motherapy with the topoisomerase inhibitor SN38
induces 95% apoptosis (cell death).
Methods
Data Acquisition and Analysis
The lipid analysis method has been previously described
in [11], an abbreviated description of the method is out-
lined below.
Cell culture
The glioma cell line U87 MG (ATCC #HTB-14) was
grown in the presence of DMEM-F12 media supplemen-
ted with 10% FBS (Cell Gro, Mediatech, Herndon, VA)
in a humidified CO2 incubator at 5% CO2. Cell cultures
were grown in 150-mm dishes to 90% confluency.
Treatment of cells
Cells (~2 × 10
6) were treated with adenoviruses (thera-
peutic Ad-p53 or DI312 control adenovirus vector) or
cytotoxic chemotherapy (SN-38), either alone, in combi-
nation or in different sequences. Cell cultures were trea-
ted for 24 h with SN-38 at a final concentration of 0.1
μM (stock solution of 10 mM).
Cell cultures were also treated with either control
virus DI312 or test virus that contained wild-type p53
gene inserted in the E1 region of the adenovirus vector
(Ad-p53) at 1:100 MOI (multiplicity of infection) from a
stock virus titered at 2.8 × 10
11 pfu (plaque-forming
units). Cell cultures that were treated with a
Figure 8 Phosphatidylinositol profiles for the two treatments U87+DI312/24hr+SN38/24hr and U87+p53/24hr+SN38/24hr.
Phosphatidylinositol (PI) profiles for the polar lipid fraction of extracts of U87 cells following the first two treatments. The effect of treatment
with wild-type wt p53, which increases the abundance of some PI, is most pronounced for the hydroxylated PIs.
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Page 11 of 15Figure 9 Graph-clustering correlation network for phosphatidylinositol showing the difference between U87+DI312/24hr+SN38/24hr
and U87+p53/24hr+SN38/24hr. Correlation network resulting from graph-clustering data analysis for a correlation threshold > 0.6 for PIs
showing the difference between the first two treatments. Despite of the visual clutter, we here retain threshold for the sake of comparability to
the above figures. Quite obviously, T1 and T2 heavily differ, with almost 7% of all pairwise differences above 0.6. Red nodes are mostly small,
which indicates little discrimination between T1 and T2 for these nodes, which in the raw data correspond to lipids with high values. Quite
noticeable, v39 = (38:6)+O shows the highest increase in T2 simply because its value is 0 in T1 but 100 in T2 while v6 = (34:2)+O, v15 = (36:3)+O,
v37 = (38:5)+3O and v54 = (40:6)+O are also significant.
Figure 10 Phosphatidylglycerol profiles for all seven treatments. Phosphatidylglycerol (PG) profiles in U87 cells following different gene
and/or chemotherapy treatments.
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Page 12 of 15combination of drug and virus included a total incuba-
tion period of 48 h allowing 24 h for each agent. Cells
were washed three times with room-temperature phos-
phate-buffered saline (PBS) between treatments. Prior to
viral infection, the cells were placed in serum-free media
for 1 hour to ensure adequate absorption of virus to the
cells. These different conditions are listed in Table 1.
Polar lipid extraction
Cells (ca. 2 × 10
6) were extracted by the addition of
methanol:chloroform 1:1 and sonicated for 30 min. The
extract was incubated overnight at 48°C in order to
optimize GSL yields. After centrifugation, the superna-
tant was collected and partitioned with additional
chloroform and H2O. The upper layer was collected and
dried. Approximately 1
50th of the total extract was con-
sumed per LC/MS experiment.
nLC/MS
The lipids were reconstituted in 80% methanol (aq) with
the addition of 10 mM NH4OAc and separated by nano-
liquid chromatography (Eksigent, Dublin, CA) in a self-









B during 4 min (Solvent A.
98% H2O, 2% methanol, and 10 mM NH4OAc; B: 98%
methanol, 2% H2O, 10 mM NH4OAc) with a flow rate of
400 nL/min. LC effluent was analyzed on-line by negative-
ion micro-electrospray and a modified hybrid linear ion
trap FT-ICR MS equipped with a 14.5 T magnet [12]. Par-
ent ion mass spectra were collected at high mass resolving
power (m/Δm50% = 200,000 at m/z 400, in which Δm50% is
spectral peak full width at half-maximum peak height) and
acquisition rate (> 1 Hz). The instrument was calibrated
with a mixture (ESI calibration solution, Thermo Fisher,
Waltham, MA) based on the quadrupolar trapping
potential approximation [30,31]. Typical broadband exter-
nal calibration mass accuracy is better than 500 ppb. Data-
dependent MS/MS was performed in the linear ion trap
(CID, collisional induced dissociation) during collection of
the ICR time-domain data [11]. Lipids were identified
based on accurate mass and CID MS/MS tandem mass
spectra in the LTQ. We compared tandem mass spectra
to those in the literature as well as collected tandem mass
spectra of lipid standards.
Comparative Lipid Quantitation
Comparative lipid quantitation was performed by a
Semi-quantitative method based on the relative ion sig-
nal magnitude detected in FT-ICR MS of specific lipid
species (glycolipid and phospholipid) for control vs.
treated samples (transfectants). FT-ICR mass spectral
signal magnitude is directly proportional to the number
of ions of that mass-to-charge ratio [32]. Lipids were
extracted, separated and analyzed under identical condi-
tions. The complexity of the spectra per scan is simpli-
fied after nLC separation. The lipid species were well
separated based on their polar head groups as well as
ceramide or acyl backbones. Thus the competition for
charge in the electrospray process is minimized as well
as dynamic range issues in detection.
Preprocessing
Although the measurement domain already is +
′ ,t h e
data has a strongly skew distribution, such that any lin-
ear scaling function lets very large values overshadow
important distinctions among smaller values. For two
measurements mu and mv we thus use the logarithm





log min{ , }




1 (we define cor(0, 0)
Figure 11 Graph-clustering correlation network for phosphatidylglycerol showing the difference between U87+DI312/24hr+SN38/24hr
and U87+p53/24hr+SN38/24hr. Correlation network with threshold 0.6 for phosphatidylglycerols for T1 and T2. Very clearly v2 = (32:0)+0 and
v4 = (32:1)+0 stand out. in T2 (colors) they abruptly behave as Cluster 1, v13 = (40:6) parallels this, but much weaker. They went from close to 0
for T1 to 100 in T2. Since the left hand nodes retain their cluster they hardly differ in T1 and T2.
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Page 13 of 15:= 0) which is a symmetric two-variate function with
codomain [0, 1]. However, preliminary models suggested
this function to be too non-disciminative; we found that
a cubic exponent yielding ω(u, v)=( c o r ( mu, mv))
3
enhances the resolution, with values well spread out in
the interval [0, 1]. Note that ω can easily incorporate
any additional data on the relationship of lipids, e.g.,
measurements on lipid signaling.
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